• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于半衰期较短蛋白质的基于阵列的配体发现平台。

An Array-Based Ligand Discovery Platform for Proteins With Short Half-Lives.

作者信息

Leifer Becky S, Doyle Shelby K, Richters André, Evans Helen L, Koehler Angela N

机构信息

David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, United States; Center for Precision Cancer Medicine, Massachusetts Institute of Technology, Cambridge, MA, United States; The Broad Institute of MIT and Harvard, Cambridge, MA, United States.

David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, United States; Center for Precision Cancer Medicine, Massachusetts Institute of Technology, Cambridge, MA, United States; The Broad Institute of MIT and Harvard, Cambridge, MA, United States; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, United States.

出版信息

Methods Enzymol. 2018;610:191-218. doi: 10.1016/bs.mie.2018.09.019. Epub 2018 Oct 19.

DOI:10.1016/bs.mie.2018.09.019
PMID:30390799
Abstract

Many promising therapeutic protein targets were previously considered "undruggable" due to a deficit in structural information to guide drug design and/or a lack of an obvious binding pocket. Fortunately, array-based methods for evaluating protein binding against large chemical libraries, such as small-molecule microarray screening, have provided one of several emerging inroads to ligand discovery for these elusive targets. Despite the advance in the area of ligand discovery for poorly structured and intrinsically disordered proteins provided by array-based technologies involving cell lysates, the extension of this technology for screening proteins with short half-lives in physiologically relevant conformations has been technically challenging. In this chapter we present a protocol for leveraging in vitro translation strategies to enable array-based screening of short-lived proteins against large small-molecule libraries for ligand discovery.

摘要

许多有前景的治疗性蛋白质靶点以前被认为是“不可成药的”,这是由于缺乏指导药物设计的结构信息和/或缺乏明显的结合口袋。幸运的是,基于阵列的评估蛋白质与大型化学文库结合的方法,如小分子微阵列筛选,为这些难以捉摸的靶点的配体发现提供了几种新兴途径之一。尽管基于细胞裂解物的阵列技术在结构不良和内在无序蛋白质的配体发现领域取得了进展,但将该技术扩展用于筛选具有生理相关构象的短半衰期蛋白质在技术上具有挑战性。在本章中,我们介绍了一种利用体外翻译策略的方案,以实现针对大型小分子文库对短寿命蛋白质进行基于阵列的筛选,用于配体发现。

相似文献

1
An Array-Based Ligand Discovery Platform for Proteins With Short Half-Lives.一种用于半衰期较短蛋白质的基于阵列的配体发现平台。
Methods Enzymol. 2018;610:191-218. doi: 10.1016/bs.mie.2018.09.019. Epub 2018 Oct 19.
2
Screening Library Design.筛选文库设计
Methods Enzymol. 2018;610:73-96. doi: 10.1016/bs.mie.2018.09.016. Epub 2018 Oct 19.
3
The Development of Protein Chips for High Throughput Screening (HTS) of Chemically Labeling Small Molecular Drugs.用于化学标记小分子药物高通量筛选(HTS)的蛋白质芯片的研发
Mini Rev Med Chem. 2016;16(10):846-50. doi: 10.2174/1389557515666150511152922.
4
Construction and application of a photo-cross-linked chemical array.光交联化学阵列的构建与应用
Methods Mol Biol. 2015;1263:29-41. doi: 10.1007/978-1-4939-2269-7_3.
5
GPCR profiling: from hits to leads and from genotype to phenotype.G蛋白偶联受体分析:从发现到先导化合物,从基因型到表型。
Drug Discov Today Technol. 2015 Nov;18:30-7. doi: 10.1016/j.ddtec.2015.10.005. Epub 2015 Nov 6.
6
Fragment-based ligand discovery.基于片段的配体发现
Mol Interv. 2009 Feb;9(1):22-30. doi: 10.1124/mi.9.1.7.
7
Chemical screening in zebrafish for novel biological and therapeutic discovery.利用斑马鱼进行化学筛选以发现新的生物学特性和治疗方法。
Methods Cell Biol. 2017;138:651-679. doi: 10.1016/bs.mcb.2016.10.004. Epub 2016 Dec 29.
8
Solid-phase biological assays for drug discovery.用于药物发现的固相生物测定法。
Annu Rev Anal Chem (Palo Alto Calif). 2014;7:337-59. doi: 10.1146/annurev-anchem-071213-020241. Epub 2014 Jun 5.
9
Experimental free ligand conformations: a missing link in structure-based drug discovery.实验性游离配体构象:基于结构的药物发现中缺失的环节。
Future Med Chem. 2019 Jan;11(2):79-82. doi: 10.4155/fmc-2018-0339. Epub 2019 Jan 16.
10
Hit-to-Lead: Hit Validation and Assessment.从活性分子到先导化合物:活性分子验证与评估
Methods Enzymol. 2018;610:265-309. doi: 10.1016/bs.mie.2018.09.022. Epub 2018 Oct 25.